Skip to main content

Table 1 Descriptive statistics of the clinical parameters measured at baseline and 6 months after surgery

From: Effects of autologous concentrated growth factor on gingival thickness in periodontal accelerated osteogenic orthodontics: a 6-month randomized controlled trial

 

Control group

Test group

pa

GT

 Baseline

0.94 ± 0.19 (0.50–1.31)

0.94 ± 0.23 (0.35–1.53)

0.733

 6 months

1.02 ± 0.16 (0.63–1.50)

1.31 ± 0.33 (0.81–2.05)

0.000**

 pb

0.000**

0.000**

 

GH

 Baseline

2.61 ± 0.51 (2.01–3.80)

2.60 ± 0.49 (1.76–3.90)

0.957

 6 months

2.69 ± 0.42 (2.01–4.11)

2.67 ± 0.35 (2.00–3.39)

0.761

 pb

0.064

0.445

 

BT

 Baseline

1.04 ± 0.48 (0.91–1.14)

1.04 ± 0.04 (0.94–1.15)

0.568

 6 months

1.43 ± 0.04 (1.31–1.56)

1.43 ± 0.06 (1.32–1.58)

0.620

 pb

0.000**

0.000**

 

BH

 Baseline

2.67 ± 0.69 (1.89–3.99)

2.71 ± 0.66 (1.21–3.85)

0.055

 6 months

1.71 ± 0.44 (1.01–2.18)

1.70 ± 0.48 (1.01–2.54)

0.088

 pb

0.000**

0.000**

 
  1. Data are expressed as the mean ± standard deviation (minimum–maximum)
  2. GT, gingival thickness; GH, gingival height; BT, buccal alveolar bone thickness; BH, buccal alveolar bone height;
  3. aMann Whitney U Test, statistically different between groups (**p < 0.01, *p < 0.05)
  4. bWilcoxon Signed Rank Test, significantly different compared with baseline (**p < 0.01,*p < 0.05)